BMS, which already has two FDA-approved CAR T-cell therapies, is eyeing entry into the growing in vivo market.

The API manufacturing site is AstraZeneca’s largest investment into in the state of Virginia to date, and will produce ADCs ...

Marketing and manufacturing practices for compounded GLP-1RA drugs come under FDA scrutiny, prompting policy changes.

Turbine and AstraZeneca have partnered to enhance the discovery of antibody-drug conjugates (ADCs) using the former’s virtual ...

Amazon Pharmacy kiosks will stock commonly used drugs such as antibiotics, inhalers, and blood pressure medications.

Novo Nordisk has agreed to buy Akero Therapeutics in a deal rising to a potential $5.2bn, as the Danish drugmaker looks to ...

Data from England’s National Health Service (NHS) shows that the flu jab has been administered to 4.3 million people, a 28% ...

Illuminating its plans, neurological disease specialist MapLight said it would offer 14,750,000 shares of its common stock at ...

The completion of the Series A marks a fast-moving year for Trogenix, which only emerged from stealth in November 2024. The ...

Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m ...

Gene therapy company Affinia Therapeutics has raised $40m in a Series C funding round, led by New Enterprise Associates (NEA) ...

Peter Marks joins former FDA colleague, Rachael Anatol at Eli Lilly, becoming the second agency worker the pharma has snapped ...